Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand 18F-FE-PE2I in Human Subjects

Conclusion: The effective dose is within the same order of magnitude as other commonly used PET imaging agents as well as DAT agents. The reasonable effective dose, together with the previously reported favorable characteristics for DAT imaging and quantification, indicates that 18F-FE-PE2I is a suitable radioligand for DAT imaging.

Source: Journal of Nuclear Medicine - August 2, 2018 Category: Nuclear Medicine Authors: Lizana, H., Johansson, L., Axelsson, J., Larsson, A., Ogren, M., Linder, J., Halldin, C., Varrone, A., Mo, S. J. Tags: Clinical Source Type: research